arrow
A

Aijun Shen

Lingang Laboratory
H-index:24
Citation Count:1,975
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Design, Synthesis, and Anti-inflammatory Activity Evaluation for Hydrazide-Based HDAC6 Targeted Protein Degraders

基于酰肼的HDAC6靶向蛋白质降解剂的设计、合成及抗炎活性评价

2025-11-010
PRE
An mRNA Vaccine for Herpes Zoster and Its Efficacy Evaluation in Naïve/Primed Murine Models

带状疱疹mRNA疫苗及其在初免/加强免疫小鼠模型中的疗效评价

2025-03-190
OA
Discovery, SAR Study of GST Inhibitors from a Novel Quinazolin-4(1H)-one Focused DNA-Encoded Library
2023-08-085
PRE
Discovery of (S)-N-(2-Amino-4-fluorophenyl)-4-(1-(3-(4-((dimethylamino)methyl)phenyl)-6-oxopyridazin-1(6H)-yl)ethyl)benzamide as Potent Class I Selective HDAC Inhibitor for Oral Anticancer Drug Candidate
2023-05-158
PRE
Adjusted degradation of BRD4 S and BRD4 L based on fine structural modifications of the pyrrolopyridone scaffold

基于吡咯并吡啶酮支架的精细结构修饰,调整了BRD4 S和BRD4 L的降解

2022-06-0110
PRE
Single-cell lipidomics with high structural specificity by mass spectrometry
2021-05-17114
OAAI
Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes
2021-01-0142
PREAI
Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling (vol 21, pg 546, 2020)
2020-09-161
OAAI
Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3-CD8+ T cells
2020-04-0944
OA
Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling

肿瘤细胞通过劫持caspase 9信号抑制辐射诱导的免疫

2020-03-30100
PREAI
Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells (vol 37, pg 1587, 2020)
2020-02-213
OAAI
A novel long non-coding RNA-ARA: Adriamycin resistance-associated (vol 87, pg 254, 2014)
2020-02-010
PREAI
Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity
2019-08-0229
PREAI
NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance
2019-07-1964
OAAI
Notch 1/2/3 mutation as a potential biomarker for immunotherapy in smokers with non-small cell lung cancer via increasing tumor mutational burden
2019-07-010
PRE
The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors
2019-03-0111
OAAI
EGFR tyrosine kinase inhibitor limits tumor relapse through enhancing anti-tumor T cell responses
2018-07-010
PRE
Design, synthesis and pharmacological evaluation of ALK and Hsp90 dual inhibitors bearing resorcinol and 2,4-diaminopyrimidine motifs

带有间苯二酚和2,4-二氨基嘧啶基序的ALK和Hsp90双重抑制剂的设计,合成和药理评价

2018-05-0129
PREAI
Identification and Therapeutic Intervention of Coactivated Anaplastic Lymphoma Kinase, Fibroblast Growth Factor Receptor 2, and Ephrin Type-A Receptor 5 Kinases in Hepatocellular Carcinoma
2018-03-2415
OAAI
A tightly controlled Src-YAP signaling axis determines therapeutic response to dasatinib in renal cell carcinoma
2018-01-0138
OAAI